Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: China Impact on Medical Devices (2025)" report has been added to ResearchAndMarkets.com's offering.China is among the top 10...
-
Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Medical Gas Pipeline System Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape,...
-
Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Carbon Fiber Chamber Doctor Blade Systems Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape,...
-
SARASOTA, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare company focused on the fertility sector, today announced it has...
-
First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial
-
Dublin, June 25, 2025 (GLOBE NEWSWIRE) -- The "Sustainable Design and Manufacture for Medical Devices Training Course (ONLINE EVENT: July 3, 2025)" has been added to ResearchAndMarkets.com's...
-
Dublin, June 20, 2025 (GLOBE NEWSWIRE) -- The "Medical Supply Delivery Service Market Outlook 2025-2034" has been added to ResearchAndMarkets.com's offering. The Medical Supply Delivery Service...
-
Dublin, June 19, 2025 (GLOBE NEWSWIRE) -- The "Medical Device Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...
-
Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner
-
CARMEL, Ind., June 17, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing...